RhumbLine Advisers’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.89M | Buy |
135,307
+3,357
| +3% | +$96.5K | ﹤0.01% | 1543 |
|
|
2025
Q1 | $4.43M | Buy |
131,950
+7,872
| +6% | +$264K | ﹤0.01% | 1419 |
|
|
2024
Q4 | $6.34M | Buy |
124,078
+15,359
| +14% | +$785K | 0.01% | 1305 |
|
|
2024
Q3 | $5.56M | Sell |
108,719
-3,600
| -3% | -$184K | 0.01% | 1374 |
|
|
2024
Q2 | $5.03M | Buy |
112,319
+3,626
| +3% | +$162K | ﹤0.01% | 1395 |
|
|
2024
Q1 | $5.09M | Buy |
108,693
+1,478
| +1% | +$69.2K | ﹤0.01% | 1411 |
|
|
2023
Q4 | $3.81M | Buy |
107,215
+661
| +0.6% | +$23.5K | ﹤0.01% | 1574 |
|
|
2023
Q3 | $3.17M | Buy |
106,554
+16,400
| +18% | +$488K | ﹤0.01% | 1606 |
|
|
2023
Q2 | $1.62M | Buy |
90,154
+8,250
| +10% | +$149K | ﹤0.01% | 2021 |
|
|
2023
Q1 | $1.32M | Buy |
81,904
+2,916
| +4% | +$46.8K | ﹤0.01% | 2011 |
|
|
2022
Q4 | $1.45M | Sell |
78,988
-7
| -0% | -$128 | ﹤0.01% | 1948 |
|
|
2022
Q3 | $1.55M | Buy |
78,995
+5,439
| +7% | +$107K | ﹤0.01% | 1902 |
|
|
2022
Q2 | $1.37M | Buy |
73,556
+25,855
| +54% | +$482K | ﹤0.01% | 1965 |
|
|
2022
Q1 | $1.05M | Buy |
47,701
+4,654
| +11% | +$102K | ﹤0.01% | 2113 |
|
|
2021
Q4 | $1.22M | Buy |
43,047
+7,644
| +22% | +$217K | ﹤0.01% | 2125 |
|
|
2021
Q3 | $745K | Buy |
35,403
+1,852
| +6% | +$39K | ﹤0.01% | 2362 |
|
|
2021
Q2 | $632K | Buy |
33,551
+5,154
| +18% | +$97.1K | ﹤0.01% | 2449 |
|
|
2021
Q1 | $434K | Sell |
28,397
-2,370
| -8% | -$36.2K | ﹤0.01% | 2556 |
|
|
2020
Q4 | $434K | Buy |
30,767
+2,780
| +10% | +$39.2K | ﹤0.01% | 2495 |
|
|
2020
Q3 | $439K | Sell |
27,987
-4,670
| -14% | -$73.3K | ﹤0.01% | 2345 |
|
|
2020
Q2 | $572K | Buy |
32,657
+19,959
| +157% | +$350K | ﹤0.01% | 2280 |
|
|
2020
Q1 | $187K | Hold |
12,698
| – | – | ﹤0.01% | 2612 |
|
|
2019
Q4 | $319K | Buy |
12,698
+72
| +0.6% | +$1.81K | ﹤0.01% | 2562 |
|
|
2019
Q3 | $190K | Sell |
12,626
-125
| -1% | -$1.88K | ﹤0.01% | 2761 |
|
|
2019
Q2 | $319K | Buy |
12,751
+2,975
| +30% | +$74.4K | ﹤0.01% | 2577 |
|
|
2019
Q1 | $223K | Buy |
9,776
+1,301
| +15% | +$29.7K | ﹤0.01% | 2705 |
|
|
2018
Q4 | $254K | Buy |
+8,475
| New | +$254K | ﹤0.01% | 2617 |
|